Real-World Treatment Persistence with Biologic Disease-Modifying Antirheumatic Drugs Among German Patients with Psoriatic Arthritis—A Retrospective Database Study

INTRODUCTION: To investigate drug survival for biologic disease-modifying antirheumatic drugs (bDMARDs) in a real-world cohort of German adult biologic-naïve patients with psoriatic arthritis (PsA). METHODS: Claims data for patients with a diagnosis of PsA, a bDMARD claims record (index date) betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Sewerin, Philipp, Borchert, Kathrin, Meise, Dominic, Schneider, Matthias, Mahlich, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991063/
https://www.ncbi.nlm.nih.gov/pubmed/33611778
http://dx.doi.org/10.1007/s40744-021-00286-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991063/
https://www.ncbi.nlm.nih.gov/pubmed/33611778
http://dx.doi.org/10.1007/s40744-021-00286-z

Ejemplares similares